These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 12-month follow-up of yoga and bio-feedback in the management of hypertension. Patel C Lancet; 1975 Jan; 1(7898):62-4. PubMed ID: 46021 [TBL] [Abstract][Full Text] [Related]
3. Yoga and bio-feedback in the management of hypertension. Patel CH Lancet; 1973 Nov; 2(7837):1053-5. PubMed ID: 4127312 [No Abstract] [Full Text] [Related]
5. High muscle sympathetic nerve activity is associated with left ventricular dysfunction in treated hypertensive patients. de Souza SB; Rocha JA; Cuoco MA; Guerra GM; Ferreira-Filho JC; Borile S; Krieger EM; Bortolotto LA; Consolim-Colombo FM Am J Hypertens; 2013 Jul; 26(7):912-7. PubMed ID: 23475700 [TBL] [Abstract][Full Text] [Related]
6. Role of yoga in management of essential hypertension. Sundar S; Agrawal SK; Singh VP; Bhattacharya SK; Udupa KN; Vaish SK Acta Cardiol; 1984; 39(3):203-8. PubMed ID: 6331698 [TBL] [Abstract][Full Text] [Related]
7. The Role of Beta-Blockers in the Treatment of Hypertension. Cruickshank JM Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711 [TBL] [Abstract][Full Text] [Related]
8. [Salt sensitivity in patients with arterial hypertension]. Babkin AP; Gladkikh VV; Pershukov IV Kardiologiia; 2010; 50(9):57-62. PubMed ID: 21118168 [TBL] [Abstract][Full Text] [Related]
9. Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. Esler M; Lambert E; Schlaich M J Appl Physiol (1985); 2010 Dec; 109(6):1996-8; discussion 2016. PubMed ID: 20185633 [No Abstract] [Full Text] [Related]
10. Yoga and biofeedback in the management of hypertension. Patel C J Psychosom Res; 1975; 19(5-6):355-60. PubMed ID: 1214232 [No Abstract] [Full Text] [Related]
11. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. Negrao CE; Negrao MV J Appl Physiol (1985); 2010 Dec; 109(6):2006. PubMed ID: 21188817 [No Abstract] [Full Text] [Related]
13. Rebuttal from Esler, Lambert, and Schlaich. Esler M; Lambert E; Schlaich M J Appl Physiol (1985); 2010 Dec; 109(6):2000-1. PubMed ID: 21148350 [No Abstract] [Full Text] [Related]
14. [Hypertension and the sympathetic nervous system - recent developments in research and treatment]. Grisk O Dtsch Med Wochenschr; 2009 Nov; 134(45):2289-93. PubMed ID: 19876804 [TBL] [Abstract][Full Text] [Related]
15. Randomised controlled trial of yoga and bio-feedback in management of hypertension. Patel C; North WR Lancet; 1975 Jul; 2(7925):93-5. PubMed ID: 49737 [TBL] [Abstract][Full Text] [Related]
16. [The control of renin secretion: experimental data and clinical implications]. Zanchetti A; Leonetti G; Morganti A; Terzoli L; Stella A Atti Soc Ital Cardiol; 1978; 37():46-59. PubMed ID: 356832 [No Abstract] [Full Text] [Related]
17. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Rohrwasser A J Appl Physiol (1985); 2010 Dec; 109(6):2007. PubMed ID: 21188818 [No Abstract] [Full Text] [Related]